
MediCarbone is an Arizona-based orthopedic medical device startup founded in 2019, specializing in a revolutionary, minimally invasive approach to intramedullary (IM) nailing for bone fracture repair. Their patented technology utilizes a carbon-fiber-reinforced polymer composite, consisting of an IM sleeve and an injectable, rapid-cure polymeric resin system. An AI tool analyzes patient data to customize the device size, shape, and materials for optimal treatment. The company has partnered with NAMSA for regulatory guidance and aims for FDA submissions. Backed by federal funds from the National Science Foundation and investment from UAVenture Capital, MediCarbone is poised to disrupt the IM market, which is projected to reach $1.2 billion by 2030.

MediCarbone is an Arizona-based orthopedic medical device startup founded in 2019, specializing in a revolutionary, minimally invasive approach to intramedullary (IM) nailing for bone fracture repair. Their patented technology utilizes a carbon-fiber-reinforced polymer composite, consisting of an IM sleeve and an injectable, rapid-cure polymeric resin system. An AI tool analyzes patient data to customize the device size, shape, and materials for optimal treatment. The company has partnered with NAMSA for regulatory guidance and aims for FDA submissions. Backed by federal funds from the National Science Foundation and investment from UAVenture Capital, MediCarbone is poised to disrupt the IM market, which is projected to reach $1.2 billion by 2030.